COVID-19: Laser Interferometry for Rapid Single Coronavirus Detection
NCT04401644 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250
Last updated 2020-05-26
Summary
Using Laser light to detect COVID 19 virus particles in deep throat swab / nasal swab samples.
Conditions
- Diagnoses Disease
- Coronavirus
Interventions
- DIAGNOSTIC_TEST
-
Novel laser inferometry test for CORONA virus
detection of virus particles by light absorbtion patterns.
Sponsors & Collaborators
-
University of Exeter
collaborator OTHER -
University of Plymouth
collaborator OTHER -
Somerset NHS Foundation Trust
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-30
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Role of Microparticles in Covid-19 Infection
NCT04448743 ·Status: COMPLETED
-
Intranasal INNA-051 for Prevention of COVID-19 in Adults
NCT05118763 ·Status: WITHDRAWN ·Phase: PHASE2
-
Concordance Between Buccal Cavity Swab and Nasopharyngeal Swab for SARS-CoV-2 (COVID-19) Detection by RT-PCR and ELISA
NCT04732637 ·Status: UNKNOWN
-
Impact of GSE and Xylitol (Xlear) on COVID-19 Symptoms and Time to PCR Negativisation in COVID-19 Patients
NCT04854486 ·Status: WITHDRAWN ·Phase: PHASE3
-
Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial)
NCT04397692 ·Status: TERMINATED ·Phase: NA
-
A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy of Lavandula Angustifolia Containing Nasal Spray Medical Device in Preventing Deterioration of COVID-19 in Symptomatic Patients
NCT04974190 ·Status: UNKNOWN ·Phase: NA
-
Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.
NCT04779047 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of SA58 Nasal Spray in Close Contact With COVID-19 People
NCT05667714 ·Status: UNKNOWN ·Phase: NA
-
Collection of Anti-SARS-CoV-2 Immune Plasma
NCT04344977 ·Status: COMPLETED
-
Seawater Nasal Wash to Relieve COVID-19 Nasal Symptoms and Reduce SARS-CoV-2 Viral Load.
NCT04916639 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years
NCT04470609 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.
NCT05785390 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate the Efficacy of IN STI-9199 in Treating Symptomatic COVID-19 in Outpatient Adults and Adolescents
NCT05372783 ·Status: WITHDRAWN ·Phase: PHASE2
-
Ivermectin Versus Standard Treatment in Mild COVID-19
NCT04937569 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)
NCT05787444 ·Status: UNKNOWN
-
Efficacy and Safety of ES16001 in Patients With COVID-19
NCT05525182 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019
NCT04310228 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients
NCT04793984 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic
NCT04668469 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19)
NCT04383574 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease
NCT04521322 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease
NCT04412395 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety, Tolerability, and Pharmacokinetics of Q-Griffithsin Intranasal Spray
NCT05437029 ·Status: UNKNOWN ·Phase: PHASE1
-
Effectiveness and Safety of New Oral Antivirals for COVID-19
NCT05894603 ·Status: UNKNOWN
-
Inhaled Ivermectin and COVID-19
NCT04681053 ·Status: UNKNOWN ·Phase: PHASE3